Correlation Between the Amplitude of Ankle Dorsiflexion and Occurrence of Patellofemoral Pain Syndrome

Sponsor

Filipe Abdalla dos Reis (Other)

Overall Status

Completed

CT.gov ID

NCT03213015

Collaborator

(none)

Enrollment

Location

Arm

5.1

Actual Duration (Months)

13.1

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of this study was to verify the clinical reliability of ankle dorsiflexion range of motion (ADROM) measurement with weight bearing (WB) using an app on the smartphone (iHand) and to verify if there is correlation between the limitation of the ADROM and the PFP.

Condition or Disease	Intervention/Treatment	Phase
Patellofemoral Pain Syndrome	Diagnostic Test: Ankle dorsiflexion measurement	N/A

Detailed Description

The change in lower extremity movement pattern has been previously associated with severe knee disorders, including anterior cruciate ligament rupture, patellar tendinopathy, iliotibial band syndrome, and patellofemoral pain (PFP). The aim of this study was to verify the clinical reliability of ankle dorsiflexion range of motion (ADROM) measurement with weight bearing (WB) using an app on the smartphone (iHand) and to verify if there is correlation between the limitation of the ADROM and the PFP.

Study Design

Study Type:

Interventional

Actual Enrollment :

67 participants

Intervention Model:

Sequential Assignment

Masking:

None (Open Label)

Primary Purpose:

Diagnostic

Official Title:

Correlation Between the Amplitude of Ankle Dorsiflexion and Occurrence of Patellofemoral Pain Syndrome

Actual Study Start Date :

Jan 25, 2017

Actual Primary Completion Date :

Mar 25, 2017

Actual Study Completion Date :

Jun 30, 2017

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Experimental Measurement of ankle dorsiflexion ROM (range of motion) with iHand app (smartphone)	Diagnostic Test: Ankle dorsiflexion measurement It was used the test with WB, called Lunge Test, in which each evaluator marked a point 15 cm distal to the anterior tuberosity of the tibia (TAT) with a felt tip pen. After that the smartphone (app iHand) will be placed at this point. Between each measurement, the mark was removed with alcohol 70% The demarcated point served as a guide for positioning the smartphone. In order to standardize the smartphone positioning, BHome (home button on the iPhone), was aligned with the TAT pen mark. To ensure the same distance from the foot to the test, the distance of the hallux to the wall was measured (tape measure), recorded and reused for each test.

Arm

Intervention/Treatment

Experimental: Experimental

Measurement of ankle dorsiflexion ROM (range of motion) with iHand app (smartphone)

Diagnostic Test: Ankle dorsiflexion measurement

It was used the test with WB, called Lunge Test, in which each evaluator marked a point 15 cm distal to the anterior tuberosity of the tibia (TAT) with a felt tip pen. After that the smartphone (app iHand) will be placed at this point. Between each measurement, the mark was removed with alcohol 70% The demarcated point served as a guide for positioning the smartphone. In order to standardize the smartphone positioning, BHome (home button on the iPhone), was aligned with the TAT pen mark. To ensure the same distance from the foot to the test, the distance of the hallux to the wall was measured (tape measure), recorded and reused for each test.

Outcome Measures

Primary Outcome Measures

Ankle Dorsiflexion Degrees [1 day]
We will evaluate the ankle range of motion (dorsiflexion) with app (iHand) in smartphone. The measurement will be in degree.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 55 Years

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

volunteers with a history of patelofemoral pain
presence of image (lesion) in cartilage tissue in Nuclear Magnetic Resonance
knee dynamic valgus during the single leg squat test and step down test (clinical tests)

Exclusion Criteria:

acute knee lesion
acute ankle lesion
surgical procedures before six months ago

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Filipe Abdalla	Campo Grande	Mato Grosso do Sul	Brazil	79117504

Sponsors and Collaborators

Filipe Abdalla dos Reis

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Filipe Abdalla dos Reis, Principal Investigator and Clinical Professor, Universidade Anhanguera

ClinicalTrials.gov Identifier:

NCT03213015

Other Study ID Numbers:

2.128.451

First Posted:

Jul 11, 2017

Last Update Posted:

Jul 13, 2017

Last Verified:

Jul 1, 2017

Individual Participant Data (IPD) Sharing Statement:

Undecided

Plan to Share IPD:

Undecided

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Filipe Abdalla dos Reis, Principal Investigator and Clinical Professor, Universidade Anhanguera

confiability

ankle

patellofemoral pain syndrome

Additional relevant MeSH terms:

Patellofemoral Pain Syndrome

Syndrome

Somatoform Disorders

Study Results

No Results Posted as of Jul 13, 2017